152 related articles for article (PubMed ID: 16677841)
21. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in skin and ocular melanoma].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S42-6. PubMed ID: 12739335
[No Abstract] [Full Text] [Related]
22. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in bronchopulmonary and pleural cancers].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S23-41. PubMed ID: 12739334
[No Abstract] [Full Text] [Related]
23. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Technical bases and regulatory principles].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S18-22. PubMed ID: 12739333
[No Abstract] [Full Text] [Related]
24. PET imaging in gynecologic malignancies.
Kumar R; Alavi A
Radiol Clin North Am; 2004 Nov; 42(6):1155-67, ix. PubMed ID: 15488564
[TBL] [Abstract][Full Text] [Related]
25. [2002 Standards, Options and Recommendations for the use of [18F]-FDG (PET-FDG) in cancerology].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S1-109. PubMed ID: 12744225
[No Abstract] [Full Text] [Related]
26. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S80-7. PubMed ID: 12739339
[No Abstract] [Full Text] [Related]
27. [(18F)-fluoro-2-deoxyglucose PET in imaging of gynecologic cancers].
Talbot JN; Grahek D; Kerrou K; Younsi N; de Beco V; Colombet-Lamau C; Petegnief Y; Cailleux N; Montravers F
Gynecol Obstet Fertil; 2001 Nov; 29(11):775-98. PubMed ID: 11770272
[TBL] [Abstract][Full Text] [Related]
28. [Clinical experience with positron emission tomography with 2-fluorine, 18F-2-deoxy-d-glucose used for the diagnosis of malignant breast neoplasms].
Tiutin L; Fadeev N; Ryzhkova D; Kostenikiv N; Arzumanov A; Savello V; Tlostanova M
Vestn Rentgenol Radiol; 2001; (6):14-8. PubMed ID: 11858029
[TBL] [Abstract][Full Text] [Related]
29. [The infusion urogram in gynecologic tumors].
Teske HJ; Heissen E
Strahlentherapie; 1969 Sep; 138(3):332-6. PubMed ID: 5349537
[No Abstract] [Full Text] [Related]
30. [A case report. FDG-PET in occult breast cancer].
Ladjevardi S; Sörensen J; Hellman P; Juhlin C; Wärnberg F
Lakartidningen; 2002 Feb; 99(6):524-6. PubMed ID: 11881227
[No Abstract] [Full Text] [Related]
31. Lymphography as a diagnostic aid in female genital malignancy.
Hodari AA; Hodgkinson CP
Obstet Gynecol; 1967 Jan; 29(1):34-43. PubMed ID: 6017943
[No Abstract] [Full Text] [Related]
32. Evaluation of 18F-FDG PET with bladder irrigation in patients with uterine and ovarian tumors.
Koyama K; Okamura T; Kawabe J; Ozawa N; Torii K; Umesaki N; Miyama M; Ochi H; Yamada R
J Nucl Med; 2003 Mar; 44(3):353-8. PubMed ID: 12621000
[TBL] [Abstract][Full Text] [Related]
33. FDG-PET: procedure guidelines for tumour imaging.
Bombardieri E; Aktolun C; Baum RP; Bishof-Delaloye A; Buscombe J; Chatal JF; Maffioli L; Moncayo R; Mortelmans L; Reske SN
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):BP115-24. PubMed ID: 14989224
[No Abstract] [Full Text] [Related]
34. [Radiological aspects in children's gynecology].
Benz G; Willich E
Fortschr Med; 1974 May; 92(15):635-40. PubMed ID: 4829460
[No Abstract] [Full Text] [Related]
35. [Guidelines for tumor diagnosis with (F-18)-fluorodeoxyglucose (FDG)].
Knapp WH
Nuklearmedizin; 1999; 38(6A):267-9. PubMed ID: 10510829
[No Abstract] [Full Text] [Related]
36. [Positron emission tomography for diagnosis of breast cancers].
Yutani K; Nishimura T
Nihon Rinsho; 2000 Apr; 58 Suppl():76-9. PubMed ID: 11025977
[No Abstract] [Full Text] [Related]
37. European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDG.
Bartenstein P; Asenbaum S; Catafau A; Halldin C; Pilowski L; Pupi A; Tatsch K;
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):BP43-8. PubMed ID: 12436498
[No Abstract] [Full Text] [Related]
38. [Clinical application of FDG-PET for cancer diagnosis].
Nakamoto Y
Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Jul; 63(6):285-93. PubMed ID: 12934545
[TBL] [Abstract][Full Text] [Related]
39. Detection of occult disease in breast cancer using fluorodeoxyglucose camera-based positron emission tomography.
Pecking AP; Mechelany-Corone C; Bertrand-Kermorgant F; Alberini JL; Floiras JL; Goupil A; Pichon MF
Clin Breast Cancer; 2001 Oct; 2(3):229-34. PubMed ID: 11899417
[TBL] [Abstract][Full Text] [Related]
40. FDG-positron emission tomographic imaging in carcinoma of the breast: interference by massive sarcoidosis.
Garcia CA; Rosenberg RJ; Spencer RP
Clin Nucl Med; 2003 Mar; 28(3):218-9. PubMed ID: 12592129
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
